|
|
| |
News Archives |
| Eskayef celebrates incentive tour at Shillong and Cherapunjee. |
A group of 170 sales and marketing people from Eskayef Bangladesh Limited visited Shillong and Cherapunjee, India very recently for better performance with their prime brand Losectil. Shillong is a city of natural beauty with hills, valleys, and fountains. The whole team enjoyed the trip in Shillong and Cherapunjee.
This is the biggest group from Eskayef house to visit Shilong and Charapunjee. This was a sales incentive tour. The team started from Dhaka to Sylhet first and then they crossed the Tamabil-Dawki border.
|
| |
| Eskayef celebrates UK MHRA accreditation in a grand iftar party |
Eskayef Bangladesh Limited celebrated the UK MHRA accreditation in a grand iftar party in Utsab, Hotel Sarina, Banani, Dhaka. Persons from all the departments of Eskayef, the MHRA team and trade officers from different embassies were present in the party.
Managing Director of Eskayef Bangladesh Limited Mr. A M Faruque in his short speech said ‘the accreditation will allow Eskayef to export tablets, capsules and granules to the UK and other European countries. The opportunity will let the company develop itself as a global supplier and enhance its contribution to foreign currency earnings’. The party ended with dinner.
|
| |
| Eskayef achieves UK MHRA accreditation. |
Eskayef Bangladesh Ltd, one of the leading manufacturers and exporters of pharmaceutical products, has won accreditation from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for its new plant at Tongi.
The accreditation will allow Eskayef to export tablets, capsules and granules to the UK and other European countries. The opportunity will let the company develop itself as a global supplier and enhance its contribution to foreign currency earnings.
The MHRA approval is one of the toughest to win and this approval will also help Eskayef to enter the highly regulated markets of Australia, South Africa and GCC countries. The company is in process to export finished drugs to the European countries.
Evaluation for MHRA accreditation is a complex process. Inspectors from the UK agency inspected Eskayef's plant, machinery and equipment, HVAC (heating, ventilation and air-conditioning) system, purified water system and effluent treatment system. The inspectors also audited the design of the company's manufacturing plant and found Eskayef compliant with the UK's Good Manufacturing Practice.
Eskayef is one of the youngest, but fastest growing, companies in both local and international markets. The company exports pharmaceutical products to around 15 countries across four continents.
Eskayef believes Bangladesh has the ability to grab a larger share of the international market for pharmaceutical products because of low manufacturing costs. The WTO agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) has enabled Bangladesh to manufacture generic drugs for exporting to other less developed countries.
The country earned $32.97 million by exporting pharmaceutical products to around 67 countries in the first nine months of the current fiscal year, registering a 60 percent increase in export earnings from the pharmaceutical sector over the same period a year ago.
|
| |
| Eskayef launches Neorice, the rice based oral saline |
Eskayef Bangladesh Limited has recently launched rice based oral saline Neorice® after their successful launching of reduce osmolarity oral saline (Neosaline®), which they launched as the pioneer brand. Rice based oral rehydration saline is the latest rehydration therapy within the chain of oral rehydration Saline’s chronological development.
In Neorice glucose is replaced with processed rice powder so that it exert lower osmotic pressure but provide more glucose than reduced osmolarity oral saline. Because Neorice provide more glucose in a slow conversion from processed rice, it carries more sodium and potassium than reduced osmolarity oral saline.
The osmotic pressure of Neorice is much lower than that of plasma, as a result fluid passed from intestine to the plasma, reducing water loss during severe diarrhea of cholera. It also reduces the frequency of stool output and vomiting.
To reconstitute the saline the powder of the sachet should be poured into ½ liter of water and then boiled for 5 minutes. After cooling the solution, it can be used for the patient. Once reconstituted, the solution can be used for 12 hours.
Neorice is available in all chemist shops allover Bangladesh in sachet of 20’s box. |
| |
| Eskayef started medicine export to Indonesia. |
Eskayef Bangladesh Limited has started exporting medicines to Indonesia. Recently Eskayef made the first shipment to Indonesia.
In 2006 the Managing Director and Head of International Business visited Indonesia with the help of Indonesian High Commission in Dhaka. During the visit Eskayef’s official persons met the Foreign Minister, Health Minister, and persons from Drug Administration and Drug Manufacturering companies of Indonesia. Following the discussion in 2007 an official team from Indonesia visited Eskayef’s facility in Bangladesh. The team was impressed and well convinced after the visit and made an agreement to take medicine from Eskayef.
Indonesia possesses a controlled market for medicine supply. Especially medicine market is strictly controlled. In spite of that Eskayef got the order from them because of high standard of drug. Eskayef is exporting medicines to many other countries too.
|
| |
| Eskayef enters cefuroxime market by launching Kilmax. |
Eskayef Bangladesh Limited has recently launched cefuroxime axetil by the brand name Kilmax, with the slogan ‘Maximum power, Maximum killing’. Eskayef launched the full range of Kilmax, i.e. 250, 500, 750mg tablet, powder for suspension, 250 & 750mg IV/IM injection. A jumping black leopard is the brand ambassador for Kilmax.
Cefuroxime axetil is a second generation bactericidal cephalosporin antibiotic, which is used for RTIs, SSTIs, UTIs, Septicemia, Gonorrhoea, Meningitis, Surgical prophylaxis etc. This is a comparatively older molecule in Bangladesh market. Eskayef is a late entrant here.
Kilmax is now available all the chemist shops allover Bangladesh. |
| |
| Eskayef stands by children with disabilities in association with CRP. |
Eskayef Bangladesh Limited recently provided Center for the Rehabilitation of the Paralyzed (CRP) with some donations for the treatment, education and development of the children with disabilities of CRP.
Managing Director of Eskayef Bangladesh Limited Mr. A M Faruque handed over the grant to Founder of CRP Valerie A Tailor in the city recently. Eskayef believes that children with disabilities are integral part of our society, proper nourishment can make them self-dependent so that they can explore their potential.
“We are happy to stand beside the children with disabilities of CRP” Chairman of CRP Board of Trustee Maj. Gen. (retd) Dr. Md. Nurul Haque and Head of Marketing of Eskayef Bangladesh Dr. Mujahidul Islam were also present on the occasion.
|
| |
| Eskayef launches Losectil Philanthropy Program. |
Eskayef Bangladesh Limited launched “Losectil Philanthropy Program” for the first time in Bangladesh. Under this program Eskayef will help the poor and meritorious students of the Govt. medical colleges. The company is committed to give them financial and logical support.
The fund of the program will be collected from each box sales of the prime omeprazole brand of Eskayef Losectil. In the history of Bangladesh Pharma market this is the first brand to contribute to the social responsibility.
The program is officially launched in August 2008 in 14 Govt. medical colleges after prior approval from the medical college authority. The medical college authorities highly appreciated the initiative taken by Eskayef for their students.
Click here for ‘Losectil Philanthropy Program’ page. Click here to download ‘Losectil Philanthropy Program’ application form.
|
| |
| Eskayef celebrates International Doctors’ Day for the first time in Bangladesh. |
On March 30, 2008, Eskayef Bangladesh Limited, a leading pharmaceutical company of the country has introduced for the 1st time in Bangladesh the concept of celebrating the ‘international Doctors’ day’. It was observed by sharing the greetings with the doctors through cards, flowers etc and paying good wishes through print & electronic media. The doctors were found overwhelmed with joy to know that they have an exclusive day, which is being observed internationally over decades and thanked Eskayef for its pioneering role to introduce it in Bangladesh. Acknowledging the very challenging job of providing the health care services to the mammoth 15 crore people of Bangladesh by only 43 thousand registered doctors (3,100 populations per doctor), Eskayef has taken the initiative to start the culture of thanking the doctors for their professional expertise and compassionate care to the mankind.
The first Doctors’ Day was observed on March 30, 1933 in the USA. The idea came from Ms. Eudora Brown Almond, wife of Barrow County, Georgia physician Charles B. Almond, M.D. The date was the anniversary of the first use of general anaesthetic in surgery. In 1958 the U.S. House of Representatives adopted a resolution to make it a national event. On March 30, 1842, Crawford W. Long, M.D., of Jefferson, Georgia, USA administered the first ether anesthesia to his patient Mr. James Venable and then operated to remove a tumor from that man’s neck. The man would swear later that he felt nothing during the surgery and was not aware it was over until he awoke. Dr. Long’s history-making achievement on that day, and the continuous efforts by physicians to alleviate human suffering in the 166 years since then, have become the basis for celebrating International Doctors Day each year.
|
| |
| Eskayef has celebrated International Doctors’ Day- 1st ever in Bangladesh |
On March 30, 2008, Eskayef Bangladesh Limited, a leading pharmaceutical company of the country has introduced for the 1st time in Bangladesh the concept of celebrating the ‘international Doctors’ day’. It was observed by sharing the greetings with the doctors through cards, flowers etc and paying good wishes through print & electronic media. The doctors were found overwhelmed with joy to know that they have an exclusive day, which is being observed internationally over decades and thanked Eskayef for its pioneering role to introduce it in Bangladesh. Acknowledging the very challenging job of providing the health care services to the mammoth 15 crore people of Bangladesh by only 43 thousand registered doctors (3,100 populations per doctor), Eskayef has taken the initiative to start the culture of thanking the doctors for their professional expertise and compassionate care to the mankind. The first Doctors’ Day was observed on March 30, 1933 in the USA. The idea came from Ms. Eudora Brown Almond, wife of Barrow County, Georgia physician Charles B. Almond, M.D. The date was the anniversary of the first use of general anaesthetic in surgery. In 1958 the U.S. House of Representatives adopted a resolution to make it a national event. On March 30, 1842, Crawford W. Long, M.D., of Jefferson, Georgia, USA administered the first ether anesthesia to his patient Mr. James Venable and then operated to remove a tumor from that man’s neck. The man would swear later that he felt nothing during the surgery and was not aware it was over until he awoke. Dr. Long’s history-making achievement on that day, and the continuous efforts by physicians to alleviate human suffering in the 166 years since then, have become the basis for celebrating International Doctors Day each year.
|
| |
| International scientific seminar on "An update on Peptic Ulcer disease" |
Eskayef Bangladesh Limited in association with Bangladesh Gastroenterology Society organized an international scientific seminar on “An update on Peptic Ulcer disease” at the BCFCC, Dhaka on April 02. Honorable Health & Family Welfare Advisor, Major General (retd.) Dr. A S M Matiur Rahman was present as the chief guest. Prof Dr. A K Azad Khan, Honorary President, Bangladesh Gastroenterology Society, chaired the seminar. The keynote speakers were Prof. Dr. Niklaus Eugen Gyr, Department of internal medicine, University of Basel, Switzerland & Dr. Mahmud Hasan, President of Bangladesh Gastroenterology Society. Mr. A M Faruque, Managing Director & Dr. Shagufa Anwar, General Manger- Marketing, Eskayef Bangladesh Ltd. were also present in the seminar. It should be mentioned here that on 27 & 30 March Eskayef Bangladesh Ltd. also sponsored two other seminars on the same topic, held in Bogra and Chittagong, participated by the local doctors. |
| |
| Annual Conference 2007 of Eskayef Bangladesh Ltd. was held at Cox’s Bazar |
The annual conference 2007 of Eskayef Bangladesh Ltd., one of the leading and fastest growing pharmaceutical companies in Bangladesh was held on 17th January 2008 at a local hotel of Cox’s Bazar. The Chairman of the company, Mr. Latifur Rahman, inaugurated the program and congratulated all for achieving the highest growth in the industry. The Managing Director of the company, Mr. A. M. Faruque highlighted the role of professionals as business executive in his speech. He also added that having attained a remarkable position in the local market, Eskayef now plans to be aggressive in venturing into global market. The General Manager Marketing Dr. Shagufa Anwar highlighted the business plan for the year 2008. The Directors of the company, Mrs. Shahnaz Rahman, Mr. Atiqur Rahman & Mr. Arshad Waliur Rahman and General Manager Sales Mr. S. K. Alauddin & General Manager Logistics Mr. Mir Mostafizur Rahman also attended the conference. The program concluded with dinner followed by a nice cultural show. |
| |
| State-of-the-art, dedicated cephalosporin plant |
True to its vision of offering newer world-class healthcare products, very soon Eskayef is going to commission a dedicated state-of-the-art cephalosporin plant under the exclusive technical supervision of one of the European pharmaceutical consultants. The new facility is being designed to conform international cGMP with particular emphasis on meeting UK MHRA standards of the UK. |
| |
| Eskayef Bangladesh Ltd. is now exporting drugs to 16 countries |
Eskayef Bangladesh Ltd. has been showing a significant outcome in exporting medicines to many countries. Eskayef Bangladesh Ltd. has started supplying medicines in 16 countries like Germany, UAE, Nepal, Bhutan, Sri Lanka, Myanmar, Vietnam, Ghana, Iraq, Indonesia, Kenya, Guatemala, Belize, Yemen, Macau and Somalia. |
| |
| New products from Eskayef house |
Eskayef Bangladesh Ltd. has recently launched Nimodi (nimodipine hydrochloride) and Ezy Xinc (zinc dispersable tablet). Nimodi (nimodipine hydrochloride) is indicated for subarachnoid hemmorhage, a sub type of stroke. Ezy Xinc (zinc dispersable tablet) can be used in the management of diarrhoea as an adjunct treatment to ORS. Eskayef Bangladesh Ltd. introduces the effervescent granule form of domperidone for the first time in Bangladesh named as Ridon EG. The syrup form of tiemonium methyl sulphate named as Timothy syrup is also first timer in Bangladesh. Aldorin (epalrestet), an aldose reductase inhibitor is launched in Bangladesh Pharmaceutical Market as the first timer. Moreover, Eskayef Bangladesh Ltd. has launched Zofra (ondensetron), Volmax (diclofenac sodium) and Efopam (nefopam hydrochloride). |
| |
| Eskayef has launched the drug of Bird Flu for the first time in Bangladesh |
In the recent emergence of avian influenza affecting many poultry firms of the country Eskayef is getting tremendous focus for its pioneering drug SK-flu in home and abroad. It needs to be mentioned here Eskayef Bangladesh Ltd. launched the drug oseltamivir for prevention and treatment of Bird Flu for the first time in Bangladesh. Its brand name is SK-flu, and it is provided in the form of 75mg capsule.
Considering the emerging threat of Bird Flu worldwide and the scarcity of its treatment, Eskayef Bangladesh Ltd. has taken the initiative of producing SK-flu as a safeguard for the people of our country. Presently the drug is stocked in Eskayef and will be dispensed on doctor’s prescription only. The recommended oral dose of SK-flu is 75mg twice daily for 5 days for the treatment and 75mg once daily for 10 days for prevention of Bird Flu. |
| |
| Managing Director, Mr. A M Faruque |
Mr. A M Faruque has been inducted as one of the directors of Transcom Group and henceforth appointed Managing Director of Eskayef Bangladesh Limited with effect from July 15, 2004. Prior to this, he was Executive Director of the company.
It is to be mentioned here; in the history of Bangladesh pharma market this is the first instance, where a private limited company, Eskayef, has appointed a Managing Director from the professionals. |
| |
|
| |
|
Latest News 